Topics

Merck steps up U.S. measles vaccine production with increased demand

17:11 EDT 1 May 2019 | Reuters

Merck & Co said on Wednesday it has increased production of the measles vaccine to meet an uptick in demand in the United States in the midst of the country's biggest outbreak in 25 years.

Original Article: Merck steps up U.S. measles vaccine production with increased demand

NEXT ARTICLE

More From BioPortfolio on "Merck steps up U.S. measles vaccine production with increased demand"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Measles
Measles (morbilli, rubeola) is a highly infectious viral illness that can be very unpleasant and can sometimes lead to serious complications.  The initial symptoms of measles develop around 10 days after initial infection: a high temperature (...

Vaccines
A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...